Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-03 Sale | 2022-01-05 4:23 pm | Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO | 100,000 | $21.1 | $2,109,800 | 1,303,070 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 6:29 pm | Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO | 270,000 | $21.82 | $5,890,487 | 367,360 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-11 Tax Withholding(A) | 2024-12-04 4:09 pm | N/A N/A | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 18,913 | $14.86 | 727,496 (Direct) | View |
| 2024-05-11 Exercise(A) | 2024-12-04 4:09 pm | N/A N/A | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 48,063 | $0 | 727,496 (Direct) | View |
| 2024-08-15 Tax Withholding | 2024-08-19 4:19 pm | N/A N/A | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 33,130 | $0 | 2,483,323 (Direct) | View |
| 2024-05-11 Tax Withholding | 2024-05-14 9:39 pm | N/A N/A | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 18,913 | $14.86 | 2,516,453 (Direct) | View |
| 2024-05-11 Exercise | 2024-05-14 9:39 pm | N/A N/A | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 48,063 | $0 | 2,516,453 (Direct) | View |
| 2024-02-23 Option Award | 2024-02-27 4:28 pm | N/A 2034-02-23 | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 632,419 | $0 | 2,487,303 (Direct) | View |
| 2023-06-06 Exercise | 2023-06-08 4:29 pm | N/A N/A | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 2,248 | $0 | 35,577 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:29 pm | N/A N/A | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 2,248 | $0 | 35,577 (Direct) | View |
| 2023-05-27 Tax Withholding | 2023-05-31 4:05 pm | N/A N/A | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 1,225 | $85.54 | 33,329 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 8:21 pm | N/A N/A | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 2,898 | $0 | 2,898 (Direct) | View |
| 2023-05-11 Option Award | 2023-05-15 5:07 pm | N/A 2030-05-11 | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 558,221 | $0 | 1,854,884 (Direct) | View |
| 2022-08-15 Option Award | 2022-08-17 7:13 pm | N/A 2029-08-15 | NEOGENOMICS INC | NEO | Smith Christopher M Chief Executive Officer | 1,296,663 | $0 | 1,296,663 (Direct) | View |
| 2022-05-27 Option Award(A) | 2022-08-01 7:17 pm | N/A N/A | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 34,554 | $0 | 34,554 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-27 5:05 pm | N/A 2032-06-22 | Akouos Inc. | AKUS | Smith Christopher M Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 6:20 pm | N/A N/A | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 2,248 | $0 | 2,248 (Direct) | View |
| 2022-05-27 Option Award | 2022-06-01 5:30 pm | N/A 2029-12-20 | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 242,538 | $0 | 242,538 (Direct) | View |
Ownership | 2022-06-01 4:59 pm | N/A N/A | QuidelOrtho Corp | QDEL | Smith Christopher M Director | 0 | $0 | 0 (Direct) | View |
| 2022-05-27 Disposition | 2022-06-01 4:15 pm | N/A 2029-12-20 | Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO | 2,338,780 | $0 | 0 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 4:23 pm | N/A 2029-12-20 | Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO | 100,000 | $0 | 1,303,070 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 4:23 pm | N/A N/A | Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO | 100,000 | $12.56 | 1,303,070 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-25 4:35 pm | N/A 2031-06-23 | Akouos Inc. | AKUS | Smith Christopher M Director | 16,000 | $0 | 16,000 (Direct) | View |
Ownership | 2021-01-27 9:10 pm | N/A N/A | Ortho Clinical Diagnostics Holdings plc | OCDX | Smith Christopher M Chairman and CEO | 0 | $0 | 1,673,070 (Direct) | View |
Ownership | 2020-06-25 7:11 pm | N/A N/A | Akouos Inc. | AKUS | Smith Christopher M Director | 0 | $0 | 39,030 (Direct) | View |